Agency / Source: STEMCELL Technologies, Inc.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

STEMCELL Technologies and Axion BioSystems Partner to Streamline Culture and Analysis of Excitable Cells - Axion BioSystems and STEMCELL Technologies are pleased to announce a strategic partnership that will enable STEMCELL to sell Axion’s state-of-the-art Maestro Pro™ and Maestro Edge™ multielectrode array (MEA) systems within North America and Europe
STEMCELL Technologies and Axion BioSystems Partner to Streamline Culture and Analysis of Excitable Cells

 

PRZOOM - /newswire/ - Atlanta, GA, United States, 2024/09/17 - Axion BioSystems and STEMCELL Technologies are pleased to announce a strategic partnership that will enable STEMCELL to sell Axion’s state-of-the-art Maestro Pro™ and Maestro Edge™ multielectrode array (MEA) systems within North America and Europe.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The industry-leading Maestro MEA systems will also continue to be available for purchase worldwide directly from Axion BioSystems. Through this partnership, Axion and STEMCELL will enable scientists to examine the complex interactions between electrical cells in vitro, driving mechanistic disease research and propelling therapeutic development in neural and cardiac fields.

Conventional electrophysiology methods, such as patch clamp, have been instrumental in establishing our understanding of cell processes and disease mechanisms in electrically active cells. However, they can be tedious and complex, requiring extensive training to collect recordings from single cells at low throughput. Maestro MEA technology makes quality electrophysiological data accessible, reducing the technical barriers and throughput limitations by measuring from a grid of microelectrodes embedded in multiwell plates. Dynamic activity patterns can be measured noninvasively across an entire population of cells, enabling researchers to record real-time responses to experimental stimuli and assess changes in cell network function over time. Versatile and user-friendly, the Maestro Pro and Edge systems make it easy to adopt advanced MEA technology, empowering researchers to address impactful experimental questions with functional data while accelerating the pace of their research.

To ensure researchers are poised for success in their MEA endeavors, STEMCELL offers a complete workflow of high-quality cells, media, reagents, and supplies to support functionally active cultures. By using Maestro MEA systems in combination with reliable, ethically sourced iPSCs or differentiated cells, BrainPhys™ Neuronal Medium, and STEMdiff™ kits (e.g., neural or cardiomyocyte), scientists can quickly achieve highly active cultures with simple, straightforward protocols, ensuring reproducible experimental results.

“As Scientists Helping Scientists, STEMCELL strives to provide researchers with innovative tools that enable the pursuit of new lines of questioning, facilitating scientific breakthroughs this collaboration does just that,” said Dr. Allen Eaves, CEO and President of STEMCELL Technologies. “Axion shares our passion, and together, our companies are uniquely positioned to provide comprehensive cell culture and functional analysis solutions to enable discoveries by scientists working in neural and cardiac research.”

According to Axion BioSystems’ CEO Julien Bradley, the collaboration advances the company’s mission to equip every lab with the power of Maestro MEA. “Since its founding in 2008 by a team of scientists, Axion’s goal has been to make high-quality, easy-to-use MEA tools more accessible. With Maestro MEA technology establishing itself as the new standard for functional analysis, especially in critical areas like mechanistic disease research and therapeutic development, we expect this new agreement with STEMCELL will accelerate groundbreaking discoveries and help improve human health.”

The complete Maestro MEA platform, including neural and cardiac analysis modules, consumables, and instrument service plans, will soon be available through STEMCELL.

About Axion BioSystems

Axion BioSystems (axionbiosystems.com) empowers scientists to reach new heights of discovery with user-friendly lab tools that deliver powerful live-cell analysis for disease research and therapeutic discovery. Designed for continuous, noninvasive monitoring of 2D and 3D cell models, Axion’s industry-leading products are widely used in academic, biotechnology, and pharmaceutical labs around the world. Axion BioSystems is headquartered in Atlanta, Georgia, USA, and has offices worldwide.

About STEMCELL Technologies

STEMCELL Technologies (stemcell.com) supports life sciences research with more than 2,500 specialized reagents, tools, and services. STEMCELL offers high-quality cell culture media, cell separation technologies, instruments, accessory products, educational resources, and contract assay services that are used by scientists performing stem cell, immunology, cancer, regenerative medicine, and cellular therapy research globally.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: STEMCELL Technologies, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


STEMCELL Technologies and Axion BioSystems Partner to Streamline Culture and Analysis of Excitable Cells

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Maestro Pro | Axion BioSystems
Contact: Press Office - Stemcell.com 
604-877-0713 marketing[.]stemcell.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any STEMCELL Technologies, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From STEMCELL Technologies, Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Press Releases:

BASF Partners with Acies Bio to Drive Sustainable Production of Personal and Home Care Ingredients
Ipsen’s Kayfanda® (odevixibat) Approved in European Union for Cholestatic Pruritus in Alagille Syndrome, A Rare Liver Disease
Frost & Sullivan Awards Avance Clinical for Global Biotech CRO Excellence, Highlighting Agility, Responsiveness, Customer Value
BASF Declares Force Majeure for Selected Vitamin A, Vitamin E, and Carotenoid Products As Well As Selected Aroma Ingredients
Ono Pharmaceutical Co., Ltd Enters into A New Option and Research Collaboration Agreement with Monash University
Aragen Life Sciences Ltd Receives the 2024 Global Customer Value Leadership Award from Frost & Sullivan for Pioneering Excellence in Drug Discovery
Ipsen’s Iqirvo® Receives U.S. FDA Accelerated Approval as A First-in-class PPAR Treatment for Primary Biliary Cholangitis
Ipsen Presents Long-term Elafibranor Efficacy and Itch-related Quality of Life Data in Patients with Primary Biliary Cholangitis
HUB Organoids B.V. Awarded Frost & Sullivan’s 2024 Technology Innovation Leadership Award for Transforming Drug Development
Immunology Consultants Laboratory Rebrand Highlights R&D and Service Specializations

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Limelon Advertising, Co.

Visit  BizJobs.com







 
  ©2005-2024 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today